NYSEMKT: OSTX
Os Therapies Inc Stock Ownership - Who owns Os Therapies?

Insider buying vs selling

Have Os Therapies Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when OSTX insiders and whales buy or sell their stock.

OSTX Shareholders

What type of owners hold Os Therapies Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Shalom Auerbach6.03%2,687,570$5.19MInsider
Paul A. Romness5.05%2,248,000$4.34MInsider
Vanguard Capital Management LLC1.05%469,467$906.07kInstitution
Theodore F. Search1.02%455,835$879.76kInsider
John Ciccio1.02%455,835$879.76kInsider
Susquehanna International Group LLP1.01%448,737$866.06kInstitution
CM Management LLC0.90%400,000$772.00kInstitution
Ubs Group Ag0.78%348,678$672.95kInstitution
Geode Capital Management LLC0.63%280,045$540.49kInstitution
Howard Financial Services Ltd0.55%245,436$473.69kInstitution

1 of 3

OSTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OSTX6.51%14.34%
ICCC15.13%21.30%Net Buying
AARD46.75%46.87%Net Buying
PYPD17.13%0.03%
BMEA33.68%25.19%Net Buying

Os Therapies Stock Ownership FAQ

Who owns Os Therapies?

Os Therapies (NYSEMKT: OSTX) is owned by 6.51% institutional shareholders, 14.34% Os Therapies insiders, and 79.15% retail investors. Shalom Auerbach is the largest individual Os Therapies shareholder, owning 2.69M shares representing 6.03% of the company. Shalom Auerbach's Os Therapies shares are currently valued at $5.19M.

If you're new to stock investing, here's how to buy Os Therapies stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.